A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors

NCT01004822 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Advanced Solid Tumors

Interventions

DRUG: CVX-241
DRUG: CVX-241
DRUG: CVX-241
DRUG: CVX-241
DRUG: CVX-241
DRUG: CVX-241
DRUG: CVX-241
DRUG: CVX-241

Sponsor

Pfizer